Lipocine (LPCN) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Lipocine (LPCN) over the last 10 years, with Q4 2024 value amounting to $1.2 million.
- Lipocine's Accumulated Depreciation & Amortization rose 347.71% to $1.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year increase of 347.71%. This contributed to the annual value of $1.2 million for FY2024, which is 347.71% up from last year.
- Per Lipocine's latest filing, its Accumulated Depreciation & Amortization stood at $1.2 million for Q4 2024, which was up 347.71% from $1.2 million recorded in Q4 2023.
- In the past 5 years, Lipocine's Accumulated Depreciation & Amortization registered a high of $1.2 million during Q4 2024, and its lowest value of $1.1 million during Q4 2021.
- Its 4-year average for Accumulated Depreciation & Amortization is $1.2 million, with a median of $1.2 million in 2022.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 82.63% in 2022, then surged by 347.71% in 2024.
- Over the past 4 years, Lipocine's Accumulated Depreciation & Amortization (Quarter) stood at $1.1 million in 2021, then increased by 0.83% to $1.2 million in 2022, then rose by 2.48% to $1.2 million in 2023, then rose by 3.48% to $1.2 million in 2024.
- Its last three reported values are $1.2 million in Q4 2024, $1.2 million for Q4 2023, and $1.2 million during Q4 2022.